Seuraa
giuliano rizzardini
giuliano rizzardini
ospedale fatebenefratelli-sacco milano
Vahvistettu sähköpostiosoite verkkotunnuksessa asst-fbf-sacco.it
Nimike
Viittaukset
Viittaukset
Vuosi
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
21392003
Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study
A Giacomelli, L Pezzati, F Conti, D Bernacchia, M Siano, L Oreni, ...
Clinical infectious diseases 71 (15), 889-890, 2020
18182020
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
15202006
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel
MA Thompson, JA Aberg, P Cahn, JSG Montaner, G Rizzardini, A Telenti, ...
Jama 304 (3), 321-333, 2010
11662010
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel
MA Thompson, JA Aberg, JF Hoy, A Telenti, C Benson, P Cahn, JJ Eron, ...
Jama 308 (4), 387-402, 2012
11622012
ABT-450/r–ombitasvir and dasabuvir with or without ribavirin for HCV
P Ferenci, D Bernstein, J Lalezari, D Cohen, Y Luo, C Cooper, E Tam, ...
New England Journal of Medicine 370 (21), 1983-1992, 2014
10142014
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
P Sarzi-Puttini, V Giorgi, S Sirotti, D Marotto, S Ardizzone, G Rizzardini, ...
Clinical and experimental rheumatology 38 (2), 337-342, 2020
5882020
Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression
S Swindells, JF Andrade-Villanueva, GJ Richmond, G Rizzardini, ...
New England Journal of Medicine 382 (12), 1112-1123, 2020
5002020
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study
HJ Stellbrink, C Orkin, JR Arribas, J Compston, J Gerstoft, ...
Clinical Infectious Diseases 51 (8), 963-972, 2010
4982010
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 …
P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ...
The Lancet 393 (10167), 143-155, 2019
4492019
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non …
ET Overton, G Richmond, G Rizzardini, H Jaeger, C Orrell, F Nagimova, ...
The Lancet 396 (10267), 1994-2005, 2020
3362020
Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis
A Gori, C Tincati, G Rizzardini, C Torti, T Quirino, M Haarman, K Ben Amor, ...
Journal of clinical microbiology 46 (2), 757-758, 2008
3042008
Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an …
G Rizzardini, D Eskesen, PC Calder, A Capetti, L Jespersen, M Clerici
British journal of nutrition 107 (6), 876-884, 2012
2952012
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study
A Giacomelli, AL Ridolfo, L Milazzo, L Oreni, D Bernacchia, M Siano, ...
Pharmacological research 158, 104931, 2020
2942020
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
2942005
Retinal findings in patients with COVID-19: Results from the SERPICO-19 study
A Invernizzi, A Torre, S Parrulli, F Zicarelli, M Schiuma, V Colombo, ...
EClinicalMedicine 27, 2020
2902020
Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients
M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ...
The Journal of infectious diseases 211 (2), 178-186, 2015
2382015
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial
A Gori, G Rizzardini, B Van't Land, KB Amor, J Van Schaik, C Torti, ...
Mucosal immunology 4 (5), 554-563, 2011
2342011
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment …
S Antinori, MV Cossu, AL Ridolfo, R Rech, C Bonazzetti, G Pagani, ...
Pharmacological research 158, 104899, 2020
2322020
Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima‐media thickness
S Piconi, D Trabattoni, C Luraghi, E Perilli, M Borelli, M Pacei, ...
The FASEB Journal 23 (4), 1196-1204, 2009
2292009
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20